• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在临床实践中使用 D-手性肌醇。

The use of D-chiro-Inositol in clinical practice.

机构信息

R&D Department, Lo.Li. Pharma Srl, Rome, Italy.

出版信息

Eur Rev Med Pharmacol Sci. 2021 Jan;25(1):438-446. doi: 10.26355/eurrev_202101_24412.

DOI:10.26355/eurrev_202101_24412
PMID:33506934
Abstract

OBJECTIVE

D-chiro-Inositol has been widely used in clinical practice to induce ovulation in women with polycystic ovary syndrome. Only recent evidence established that this molecule acts through two different mechanisms, with potentially different outcomes. On the one hand, under a metabolic perspective, D-chiro-Inositol improves insulin signaling, thus restoring physiological insulin levels in resistant subjects. On the other hand, at a cellular level, it downregulates the expression of steroidogenic enzyme aromatase, which is responsible for the conversion of androgens to estrogens.

MATERIALS AND METHODS

We reviewed current literature in different databases, searching for D-chiro-Inositol in relation with one of the following keywords: myo-inositol, PCOS, infertility, insulin resistance, aromatase, androgen and inositol, testosterone, estrogen and inositol, estradiol, hypogonadotropic hypogonadism, fat tissue, estrogens and cancer, anovulation, uterine myoma, endometriosis, endometrial hyperplasia.

RESULTS

D-Chiro-Inositol treatment may be helpful in restoring physiological hormonal levels in various clinical disorders. However, D-Chiro-Inositol intervention should be carefully designed to avoid possible undesired side effects stemming from its multiple mechanisms of action.

CONCLUSIONS

We evaluated the optimal D Chiro-Inositol administration for different pathologies, defining dosages and timing. Even though further studies are required to validate our preliminary results, this paper is primarily intended to guide researchers through some of the pathways of D-Chiro-Inositol.

摘要

目的

D-手性肌醇已广泛用于临床实践中,以诱导多囊卵巢综合征女性排卵。只有最近的证据表明,这种分子通过两种不同的机制起作用,可能有不同的结果。一方面,从代谢的角度来看,D-手性肌醇改善胰岛素信号,从而恢复抵抗性患者的生理胰岛素水平。另一方面,在细胞水平上,它下调了合成酶芳香酶的表达,芳香酶负责将雄激素转化为雌激素。

材料和方法

我们在不同的数据库中回顾了当前的文献,搜索与以下关键词之一有关的 D-手性肌醇:肌醇、多囊卵巢综合征、不孕、胰岛素抵抗、芳香酶、雄激素和肌醇、睾丸激素、雌激素和肌醇、雌二醇、促性腺激素缺乏性性腺功能减退症、脂肪组织、雌激素和癌症、排卵障碍、子宫肌瘤、子宫内膜异位症、子宫内膜增生。

结果

D-手性肌醇治疗可能有助于恢复各种临床疾病的生理激素水平。然而,D-手性肌醇的干预应仔细设计,以避免其多种作用机制可能产生的不良副作用。

结论

我们评估了不同病理情况下 D 手性肌醇的最佳给药剂量和时间。尽管还需要进一步的研究来验证我们的初步结果,但本文主要旨在通过 D-手性肌醇的一些途径为研究人员提供指导。

相似文献

1
The use of D-chiro-Inositol in clinical practice.在临床实践中使用 D-手性肌醇。
Eur Rev Med Pharmacol Sci. 2021 Jan;25(1):438-446. doi: 10.26355/eurrev_202101_24412.
2
The Role of Inositols in the Hyperandrogenic Phenotypes of PCOS: A Re-Reading of Larner's Results.多囊卵巢综合征高雄激素表型中肌醇的作用:重新解读拉纳的研究结果。
Int J Mol Sci. 2023 Mar 27;24(7):6296. doi: 10.3390/ijms24076296.
3
<sc>d</sc>-Chiro-Inositol in Clinical Practice: A Perspective from the Experts Group on Inositol in Basic and Clinical Research (EGOI).《临床实践中的 D-手性肌醇:基础与临床研究手性肌醇专家组(EGOI)的观点》。
Gynecol Obstet Invest. 2024;89(4):284-294. doi: 10.1159/000536081. Epub 2024 Feb 19.
4
Inositols: From Established Knowledge to Novel Approaches.肌醇:从已有知识到新方法。
Int J Mol Sci. 2021 Sep 30;22(19):10575. doi: 10.3390/ijms221910575.
5
Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with PCOS: a network meta-analysis.口服胰岛素增敏剂二甲双胍、噻唑烷二酮类、肌醇和小檗碱改善多囊卵巢综合征女性内分泌和代谢谱的疗效比较:网络荟萃分析。
Reprod Health. 2021 Aug 18;18(1):171. doi: 10.1186/s12978-021-01207-7.
6
Updates on the myo-inositol plus D-chiro-inositol combined therapy in polycystic ovary syndrome.多囊卵巢综合征中肌醇加D-手性肌醇联合治疗的研究进展
Expert Rev Clin Pharmacol. 2014 Sep;7(5):623-31. doi: 10.1586/17512433.2014.925795. Epub 2014 Jun 5.
7
D-chiro-inositol Induces Ovulation in Non-Polycystic Ovary Syndrome (PCOS), Non-Insulin-Resistant Young Women, Likely by Modulating Aromatase Expression: A Report of 2 Cases.D-手性肌醇诱导非多囊卵巢综合征(PCOS)、非胰岛素抵抗年轻女性排卵,可能通过调节芳香化酶表达:2 例报告。
Am J Case Rep. 2021 Oct 7;22:e932722. doi: 10.12659/AJCR.932722.
8
The rationale of the myo-inositol and D-chiro-inositol combined treatment for polycystic ovary syndrome.肌醇与D-手性肌醇联合治疗多囊卵巢综合征的理论依据。
J Clin Pharmacol. 2014 Oct;54(10):1079-92. doi: 10.1002/jcph.362. Epub 2014 Jul 18.
9
Treatment with d-chiro-inositol and alpha lipoic acid in the management of polycystic ovary syndrome.用 D-手性肌醇和α-硫辛酸治疗多囊卵巢综合征。
Gynecol Endocrinol. 2019 Jun;35(6):506-510. doi: 10.1080/09513590.2018.1540573. Epub 2019 Jan 7.
10
Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome.D-手性肌醇对多囊卵巢综合征的排卵及代谢影响
N Engl J Med. 1999 Apr 29;340(17):1314-20. doi: 10.1056/NEJM199904293401703.

引用本文的文献

1
Epigenetics of Endometrial Cancer: The Role of Chromatin Modifications and Medicolegal Implications.子宫内膜癌的表观遗传学:染色质修饰的作用及法医学意义
Int J Mol Sci. 2025 Jul 29;26(15):7306. doi: 10.3390/ijms26157306.
2
Unexpected effects of treating insulin-resistant obese women with high-dose D-chiro-inositol: opening Pandora's box.用高剂量D-手性肌醇治疗胰岛素抵抗肥胖女性的意外效果:打开潘多拉魔盒。
Front Endocrinol (Lausanne). 2025 Apr 1;16:1399308. doi: 10.3389/fendo.2025.1399308. eCollection 2025.
3
D-chiro-inositol effectively counteracts endometriosis in a mouse model.
D-手性肌醇在小鼠模型中可有效对抗子宫内膜异位症。
Mol Med. 2025 Apr 11;31(1):134. doi: 10.1186/s10020-025-01178-6.
4
Myo-Inositol and D-Chiro-Inositol Reduce DHT-Stimulated Changes in the Steroidogenic Activity of Adult Granulosa Cell Tumors.肌醇和 D-手性肌醇可降低 DHT 刺激的成年颗粒细胞瘤类固醇生成活性的改变。
Int J Mol Sci. 2024 Oct 12;25(20):10974. doi: 10.3390/ijms252010974.
5
Treatment With a Patented 3.6:1 Myo-Inositol to D-chiro-Inositol Ratio, Antioxidants, Vitamins and Minerals Food Supplement in Women With a History of Assisted Reproductive Technique (ART) Failures: A Series of Case Reports.采用专利的3.6:1肌醇与D-手性肌醇比例、抗氧化剂、维生素和矿物质的食品补充剂治疗有辅助生殖技术(ART)失败史的女性:一系列病例报告。
Clin Med Insights Case Rep. 2024 Mar 29;17:11795476241242265. doi: 10.1177/11795476241242265. eCollection 2024.
6
<sc>d</sc>-Chiro-Inositol in Clinical Practice: A Perspective from the Experts Group on Inositol in Basic and Clinical Research (EGOI).《临床实践中的 D-手性肌醇:基础与临床研究手性肌醇专家组(EGOI)的观点》。
Gynecol Obstet Invest. 2024;89(4):284-294. doi: 10.1159/000536081. Epub 2024 Feb 19.
7
The impact of epigallocatechin gallate, vitamin D, and D-chiro-inositol on early surgical outcomes of laparoscopic myomectomy: a pilot study.没食子儿茶素没食子酸酯、维生素 D 和 D-手性肌醇对腹腔镜子宫肌瘤剔除术早期手术结局的影响:一项初步研究。
Arch Gynecol Obstet. 2024 Mar;309(3):1021-1026. doi: 10.1007/s00404-023-07324-x. Epub 2024 Jan 6.
8
Stereoselective Voltammetric Biosensor for Myo-Inositol and D-Chiro-Inositol Recognition.手性立体选择伏安生物传感器用于肌醇和 D-手性肌醇的识别。
Sensors (Basel). 2023 Nov 16;23(22):9211. doi: 10.3390/s23229211.
9
D-Chiro-Inositol in Endometrial Hyperplasia: A Pilot Study.地胆草素在子宫内膜增生中的作用:一项初步研究。
Int J Mol Sci. 2023 Jun 13;24(12):10080. doi: 10.3390/ijms241210080.
10
Changes in the Carbohydrate Profile in Common Buckwheat ( Moench) Seedlings Induced by Cold Stress and Dehydration.低温胁迫和脱水诱导的普通荞麦(蓼科)幼苗碳水化合物谱变化
Metabolites. 2023 May 19;13(5):672. doi: 10.3390/metabo13050672.